| Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis LM Byrne, FB Rodrigues, K Blennow, A Durr, BR Leavitt, RAC Roos, ... The Lancet Neurology 16 (8), 601-609, 2017 | 336 | 2017 |
| Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis RI Scahill, P Zeun, K Osborne-Crowley, EB Johnson, S Gregory, C Parker, ... The Lancet Neurology 19 (6), 502-512, 2020 | 149 | 2020 |
| Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington’s disease LM Byrne, FB Rodrigues, EB Johnson, PA Wijeratne, E De Vita, ... Science translational medicine 10 (458), eaat7108, 2018 | 148 | 2018 |
| Neurofilament light protein in blood predicts regional atrophy in Huntington disease EB Johnson, LM Byrne, S Gregory, FB Rodrigues, K Blennow, A Durr, ... Neurology 90 (8), e717-e723, 2018 | 82 | 2018 |
| Cerebrospinal fluid biomarkers for Huntington’s disease LM Byrne, EJ Wild Journal of Huntington's disease 5 (1), 1-13, 2016 | 80 | 2016 |
| Cerebrospinal fluid inflammatory biomarkers reflect clinical severity in Huntington’s disease FB Rodrigues, LM Byrne, P McColgan, N Robertson, SJ Tabrizi, ... PloS one 11 (9), e0163479, 2016 | 73 | 2016 |
| Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington’s disease FB Rodrigues, LM Byrne, R Tortelli, EB Johnson, PA Wijeratne, M Arridge, ... Science translational medicine 12 (574), eabc2888, 2020 | 72 | 2020 |
| Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease FB Rodrigues, L Byrne, P McColgan, N Robertson, SJ Tabrizi, BR Leavitt, ... Journal of neurochemistry 139 (1), 22-25, 2016 | 68 | 2016 |
| Validation of ultrasensitive mutant huntingtin detection in human cerebrospinal fluid by single molecule counting immunoassay V Fodale, R Boggio, M Daldin, C Cariulo, MC Spiezia, LM Byrne, ... Journal of Huntington's disease 6 (4), 349-361, 2017 | 62 | 2017 |
| Mutant huntingtin is cleared from the brain via active mechanisms in Huntington disease NS Caron, R Banos, C Yanick, AE Aly, LM Byrne, ED Smith, Y Xie, ... Journal of Neuroscience 41 (4), 780-796, 2021 | 47 | 2021 |
| Huntington’s disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization II Sanchez, TB Nguyen, WE England, RG Lim, AQ Vu, R Miramontes, ... The Journal of clinical investigation 131 (12), 2021 | 38 | 2021 |
| Biofluid biomarkers in Huntington’s disease FB Rodrigues, LM Byrne, EJ Wild Huntington’s disease, 329-396, 2018 | 31 | 2018 |
| Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease FB Rodrigues, LM Byrne, AJ Lowe, R Tortelli, M Heins, G Flik, ... Journal of neurochemistry 158 (2), 539-553, 2021 | 22 | 2021 |
| Characterizing white matter in Huntington's disease S Gregory, E Johnson, LM Byrne, FB Rodrigues, A Henderson, J Moss, ... Movement Disorders Clinical Practice 7 (1), 52-60, 2020 | 22 | 2020 |
| A remote digital monitoring platform to assess cognitive and motor symptoms in Huntington disease: cross-sectional validation study F Lipsmeier, C Simillion, A Bamdadian, R Tortelli, LM Byrne, YP Zhang, ... Journal of Medical Internet Research 24 (6), e32997, 2022 | 19 | 2022 |
| Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s disease ZYA Ou, LM Byrne, FB Rodrigues, R Tortelli, EB Johnson, MS Foiani, ... Scientific Reports 11 (1), 3481, 2021 | 17 | 2021 |
| Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington’s disease AJ Lowe, S Sjödin, FB Rodrigues, LM Byrne, K Blennow, R Tortelli, ... PLoS One 15 (8), e0233820, 2020 | 11 | 2020 |
| Neurofilament light protein as a potential blood biomarker for Huntington's disease in children LM Byrne, JL Schultz, FB Rodrigues, E van Der Plas, D Langbehn, ... Movement disorders 37 (7), 1526-1531, 2022 | 10 | 2022 |
| Longitudinal dynamics of mutant huntingtin and neurofilament light in Huntington’s disease: The prospective HD-CSF study FB Rodrigues, LM Byrne, R Tortelli, EB Johnson, PA Wijeratne, M Arridge, ... medRxiv, 2020.03. 31.20045260, 2020 | 7 | 2020 |
| Cerebrospinal fluid flow dynamics in Huntington's disease evaluated by phase contrast MRI FB Rodrigues, LM Byrne, E De Vita, EB Johnson, NZ Hobbs, JS Thornton, ... European Journal of Neuroscience 49 (12), 1632-1639, 2019 | 6 | 2019 |
Filipe Brogueira RodriguesMedical Director, MedpaceVerified email at medpace.com
